Loading the session
Loading the session
Loading instrument
$77.20
+6.67%Market closedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:25 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
The 4 Nov 2026 gain of 6.8% was 5.3× its average daily move of 1.3% over the past year, and its largest one-day gain since 9 Apr 2025.
Daily closes, split-adjusted · as of 4 Nov 2026
The 4 Nov 2026 close of $77.31 was 14.2% above its 50-day average ($67.70) and 7.6% above its 200-day average ($71.88). It has closed above the 200-day for 3 sessions, since 2 Nov 2026. The 50-day average crossed below the 200-day on 2 Jun 2025, 359 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
1 month: +22.3% (SPY −1.6%). 3 months: +9.6% (SPY −0.4%). 1 year: +4.2% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ALC, SPY · as of 4 Nov 2026
19.6M shares were sold short at the 15 Oct 2026 settlement; covering them would take 10.9 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
The 14-session relative strength index closed at 76.0 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
May 6, 2026
−12.14%August 20, 2025
−10.08%May 14, 2024
+10.33%